Unigrilin 20 (Eptifibatide Vials) 20mg/10ml

Unigrilin 20 is an antiplatelet medication containing eptifibatide, available in 20mg/10ml vials for intravenous use. It helps prevent blood clots in conditions requiring platelet inhibition. Store between 2-8°C and protect from light. Not for self-administration.

Strength

20mg/10ml

Pack Size

1's

Storage

2-8°

Manufacturer / TM Owner

United Biotech (P) Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eptifibatide, the active ingredient in Unigrilin 20, is used to reduce the risk of blood clots in patients undergoing certain cardiac procedures or experiencing acute coronary syndromes. It works by preventing platelets from clumping together, which can block blood flow. This medication is typically administered in a clinical setting where healthcare professionals can monitor its effects.

Side Effects

Unigrilin 20 helps maintain blood flow by reducing the formation of harmful blood clots. Patients may notice improved circulation in treated areas as the medication takes effect. Some individuals report reduced chest discomfort when the drug is used for heart-related conditions. Effects are monitored closely during administration.

Precautions & Warnings

Unigrilin 20 should only be handled and administered by trained healthcare professionals. Keep vials refrigerated between 2-8°C and protect from light. Avoid shaking the vial to maintain product integrity. Inform your healthcare provider about any bleeding disorders or recent surgeries before use.

Avoid Interactions

Unigrilin 20 may interact with other medications that affect blood clotting, such as anticoagulants or nonsteroidal anti-inflammatory drugs (NSAIDs). Combining it with certain drugs could increase bleeding risk. Alcohol and herbal supplements may also interact; consult your doctor before concurrent use. Always disclose all medications to your healthcare provider.

Frequently Asked Questions

Unigrilin 20 is used to prevent blood clots in patients undergoing cardiac procedures or with acute coronary syndromes.

It is given intravenously by healthcare professionals in a clinical setting.

Unigrilin 20 requires a prescription and should only be obtained through licensed pharmacies or healthcare providers.

Common effects may include bleeding or bruising at the injection site; monitor for unusual bleeding.

Consult your doctor; safety during pregnancy has not been established and should be evaluated case-by-case.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.